Back

Lipid lowering therapy in peripheral vascular disease. Which targets? Which drugs?

25 August 2018 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice? Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ileana Desormais

University Hospital of Limoges, Limoges (France)

3 More presentations in this session

Presentation thumbnail
Antidiabetic agents in lower extremity artery disease: save the patient? Save the limb?
Professor M. Vrsalovic (Zagreb, HR)
Slides Video
Presentation thumbnail
The COMPASS trial: a new paradigm in lower extremity artery disease?
Professor O. Berwanger (London, GB)
Slides Video
Presentation thumbnail
Revascularisation in peripheral artery disease
Professor M. Venermo (Helsinki, FI)
Slides Video

Access the full session

Session thumbnail
Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice?

The Event

Event poster

ESC Congress 2018

25 August 2018 11:45 CET
You may be interested in
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022
thumbnail
Congress Session
Optimising cholesterol levels through dietary interventions: key strategies and evidence
23 June 2023
thumbnail
Congress Presentation
The influence of triglyceride and low-density-lipoprotein target levels on microcirculation
4 April 2025
thumbnail
Congress Presentation
Efficacy of PCSK9 inhibitors in patients with peripheral artery disease: insights from the AT-TARGET-IT Registry
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources